Background: Tramadol is a centrally acting synthetic analgesic agent with opioid activity. Tramadol is used to treat moderate to severe pain. The entorhinal cortex has initially attracted attention because of its strong reciprocal connections with the hippocampal formation and its involvement in certain brain disorders. Aim of work: The present study was designed to assess the deleterious effects of tramadol on the entorhinal cortex of the adult male albino rats. Materials and methods: The study was carried out on 40 adult male rats. The rats were divided equally into two groups: control group, received 1 ml normal saline 0.9% intraperitoneally for 4 weeks. Treated group received 50 mg/kg/day of tramadol intraperitoneally for 4 weeks. All animals were anaesthetized by ether inhalation and perfused by normal saline. The brains were extracted from the skulls. For light microscopy, the brains of 10 animals in each group were processed for paraffin sections and stained by Gallocyanine stain. For electron microscopy, the entorhinal cortex was dissected in 10 brains of each group and processed. Semithin sections were prepared and stained with toluidine blue. Morphometric and statistical studies were performed. Results: By light microscopy, the treated groups showed neuronal cells disorganization. Apoptotic cells were detected. In addition, diffuse chromatolysis of nuclear chromatin, absence of nucleoli, multinuclear cells, intercellular edema and a congested blood capillary were noticed. By electron microscopy, the treated groups of both lateral and medial entorhinal areas showed granular and pyramidal apoptotic cells. The morphometric and statistical studies showed significant increase of apoptotic index % in treated group as compared with control group.
Background:The most common disorders of the thyroid gland are hyperthyroidism and hypothyroidism. Both have been linked to cell damage. Aim of Work: This study was designed to evaluate the effect of melatonin administration on the testis of both hyperthyroidic and hypothyroidic adult male albino rats models. Materials and Methods: Fifty adult male albino rats were used in this study and divided into five groups; ten rats each. Control group (G1) was given distilled water. Hyperthyroidic group (G2) was given thyroxin (0.2 mg/kg b.w). Hyperthyroidic+melatonin group (G3) was given thyroxin (0.2 mg/kg b.w) and melatonin (2.5 mg / kg b.w). Hypothyroidic group (G4) was given carbimazole (1.35 mg/kg b.w). Hypothyroidic+melatonin group (G5) was given carbimazole (1.35 mg/kg b.w) and melatonin (2.5 mg / kg b.w). All the treatments were given orally for 15 days. At the end of the study, the animals of all groups were sacrificed and their testes were rapidly dissected out. The testicular mass was calculated. Testicular specimens of each group were processed for light and electron microscopic studies. Results: The testicular mass was significantly decreased in both hyperthyroidic group (G2) and hypothyroidic group (G4) when compared with the control. Light and electron microscopy of the hyperthyroidic group (G2) and hypothyroidic group (G4) showed seminiferous tubular germ cells disorganization with increased intercellular spaces, necrosis and cellular damage. Melatonin supplementation to rats given Thyroxin (G3) improved the testicular mass and the cell damage. On the contrary, melatonin supplementation to rats given carbimazole (G5) did not show any improvement on both morphometrical and histological levels. Conclusion: It was concluded that simultaneous melatonin administration effectively depresses the negative effects of hyperthyroidism but not hypothyroidism on the adult male rat testis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.